Related Experiment Video
Updated: Sep 11, 2025

09:52
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
13.5K
Multifocal Kaposiform Hemangioendothelioma Successfully Treated With Sirolimus Monotherapy
Matthew J Mahoney1, Erin P Fritz2, Alex C Hoover3
1Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.
Pediatric Dermatology
|August 17, 2025
Summary
Kaposiform hemangioendothelioma (KHE), a rare infant tumor, can be challenging to diagnose. Sirolimus monotherapy effectively treated a multifocal KHE case complicated by Kasabach-Merritt phenomenon (KMP).
Area of Science:
- Vascular Tumors
- Pediatric Oncology
- Dermatology
Background:
- Kaposiform hemangioendothelioma (KHE) is a rare vascular neoplasm predominantly affecting infants.
- KHE can present multifocally and may be associated with Kasabach-Merritt phenomenon (KMP), a serious coagulopathy.
- Early and accurate diagnosis is crucial for effective management.
Observation:
- A case of multifocal KHE on an infant's leg, initially misdiagnosed as a reticulate port wine birthmark.
- Diagnostic confirmation was achieved through skin biopsy and advanced imaging.
- The patient developed Kasabach-Merritt phenomenon (KMP), indicating disease complexity.
Findings:
- Multifocal KHE on the leg was confirmed via histopathology and imaging.
- Sirolimus monotherapy was initiated due to the presence of KMP.
- Significant clinical improvement was observed following sirolimus treatment.
Implications:
- This case highlights the importance of considering KHE in infants with atypical vascular lesions.
- Sirolimus monotherapy demonstrates efficacy in managing complex KHE cases with KMP.
- Further research into optimal KHE and KMP treatment strategies is warranted.
Keywords:
Kaposiform hemangioendotheliomaKasabach–Merritt phenomenonpediatricssirolimusvascular tissue neoplasmsMore Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
225
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
225
Open Angle Glaucoma: Treatment
568
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
568

